Since the GCP (E6 R1) was first released in 1996, clinical trials have evolved substantially in complexity, technological capabilities, and costs. ICH E6(R1) has been amended to encourage implementation of… read more →
We are excited to announce the opening of our new office in Melbourne Melbourne is globally recognised as a leading Biotech innovation hub and Mobius has several large projects running… read more →
For many years, Australia has been the one of the most attractive countries to perform clinical investigations for medical devices, pharmaceuticals and in-vitro diagnostics. The Clinical Notification Scheme (CTN) is… read more →
Mobius Medical is pleased to announce that BSI has granted ISO:9001 certification for our Quality Management System. We’re proud of our QMS having worked on it over several years to… read more →
Attending AdvaMed in Minneapolis this year are the two founding members and Principals of the SME’s favoured boutique CRO in Australia and New Zealand Stefan Czyniewski and Suzanne Williams will be… read more →
We’re looking for amazing people skills, confidence and ability to get along with the trickiest of site staff, and a happy, can-do attitude is essential. Technical skills, GCP practical… read more →
Principal investigators are often asked by their patients if they can still access the investigational product (IP) after they have completed the clinical trial. In some medical device trials, using… read more →
Mobius is delighted by the news of Prof. Gordian Fulde being named Senior Australian of the Year this week. Suzanne, one of the Principals of Mobius Medical has had the… read more →
Australia and New Zealand have each registered more clinical trials (per capita) than Germany, UK and the USA according to the World Health Organisation International Clinical Trials Registry Platform! The… read more →
Recent Comments